Le Lézard7h
BioVaxys Developing DPX to be the Carrier of Choice for mRNA Vaccines, a market projected to grow to USD$48,000,000,000 by 2030*
BioVaxys Technology Corp. (FRA: 5LB) ("BioVaxys" or the "Company") highlights the potential for its DPXtm non-systemic immune educating platform to address the inherent limitations of lipid ...
Targeted Oncology1h
What Is Dark Zone Lymphoma, and Is It Clinically Relevant?
Dark zone lymphoma includes aggressive B-cell lymphomas with shared molecular features. While some respond to escalated ...
Immune complex removes receptors from stem cells to protect against cancer, preclinical study finds
A group of immune proteins called the inflammasome can help prevent blood stem cells from becoming malignant by removing ...
Single flu shot effective for blood cancer patients, study finds
New research published in the New England Journal of Medicine has shown a single dose of the influenza vaccine is sufficient ...
Future Market Insights14h
Global Allogeneic T-cell Therapies Market Poised for Significant Growth, Projected to Reach USD 3.08 Billion by 2033 register a CAGR of 9.8%
According to a recent report from Future Market Insights, the global allogeneic T-cell therapies market was valued at USD 1.1 ...
Cure Today19h
Amy Brewster
BLA Has Been Submitted For Kidney Cancer Imaging PET Product Zircaix ...
Cure Today19h
Ann Silberman
Minoxidil May Safely Aid in Hair Growth for Patients With Breast Cancer ...